Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Tubules, Proximal | 2 | 2004 | 416 | 0.390 |
Why?
|
| Phospholipases A | 2 | 2006 | 216 | 0.280 |
Why?
|
| Receptors, Virus | 2 | 2005 | 648 | 0.250 |
Why?
|
| Glomerular Mesangium | 1 | 2003 | 108 | 0.220 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 119 | 0.220 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 434 | 0.200 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 288 | 0.190 |
Why?
|
| Vasculitis | 1 | 2003 | 519 | 0.160 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3768 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 1602 | 0.140 |
Why?
|
| Acute Kidney Injury | 2 | 2004 | 1972 | 0.120 |
Why?
|
| Kidney Tubular Necrosis, Acute | 2 | 2004 | 66 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2005 | 3143 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 4262 | 0.080 |
Why?
|
| Group II Phospholipases A2 | 2 | 2006 | 13 | 0.080 |
Why?
|
| Group V Phospholipases A2 | 2 | 2006 | 25 | 0.070 |
Why?
|
| Phospholipases A2 | 2 | 2006 | 203 | 0.070 |
Why?
|
| Eosinophil-Derived Neurotoxin | 1 | 2006 | 13 | 0.070 |
Why?
|
| Zymosan | 1 | 2006 | 124 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2002 | 7880 | 0.060 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2004 | 37 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 318 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 251 | 0.060 |
Why?
|
| Lipocalins | 1 | 2004 | 170 | 0.060 |
Why?
|
| Acute-Phase Proteins | 1 | 2004 | 262 | 0.060 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2003 | 60 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2004 | 249 | 0.060 |
Why?
|
| Myeloblastin | 1 | 2003 | 101 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 453 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 480 | 0.050 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2006 | 484 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2006 | 1539 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2005 | 1842 | 0.040 |
Why?
|
| Peroxidase | 1 | 2003 | 611 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 3870 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 731 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2005 | 1050 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1285 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 1072 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1676 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2003 | 1530 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 6895 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4554 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3086 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2006 | 21746 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2006 | 4838 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 57776 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15076 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 279 | 0.020 |
Why?
|
| Phagosomes | 1 | 2006 | 193 | 0.020 |
Why?
|
| Incidence | 1 | 2003 | 20947 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 410 | 0.020 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2006 | 221 | 0.010 |
Why?
|
| Osteopontin | 1 | 2006 | 296 | 0.010 |
Why?
|
| Eicosanoids | 1 | 2006 | 279 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 503 | 0.010 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2006 | 271 | 0.010 |
Why?
|
| Endosomes | 1 | 2006 | 520 | 0.010 |
Why?
|
| Glycosylation | 1 | 2006 | 1126 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 11124 | 0.010 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2006 | 506 | 0.010 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2006 | 450 | 0.010 |
Why?
|
| Male | 3 | 2005 | 350118 | 0.010 |
Why?
|
| Humans | 5 | 2006 | 744343 | 0.010 |
Why?
|
| Aged | 2 | 2003 | 163280 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 1988 | 0.010 |
Why?
|
| Mice | 2 | 2006 | 81183 | 0.010 |
Why?
|
| Middle Aged | 2 | 2003 | 213383 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2006 | 3616 | 0.010 |
Why?
|
| Female | 3 | 2006 | 380194 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 72290 | 0.010 |
Why?
|
| Proteome | 1 | 2006 | 1799 | 0.010 |
Why?
|
| Animals | 2 | 2006 | 168757 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13815 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14557 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19229 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 29063 | 0.000 |
Why?
|
Concepts
(78)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_